With multiple variants of a vaccine for COVID-19 on the brink of approval and manufacturing, concerns are arising about the ability of supply chains to distribute hundreds of millions of doses quickly and safely to healthcare providers throughout the country.
Brian Alster, head of third-party risk and compliance solutions with Dun & Bradstreet, outlines the steps that procurement organizations should be taking to guard against a growing number of potentially devastating cyber attacks.
Bill Brooks, vice president of transportation with Capgemini North America, Inc., lays out the multiple challenges involved in manufacturing, storing and delivering millions of doses of the vaccine for COVID-19 in the coming months.